MCM7 and hepatocellular carcinoma: Previous studies have indicated that MCM7 is upregulated in HCC and regulated by miRNA-214 and arsenic trioxide (ATO), potentially affecting HCC progression via the PI3K/AKT pathway [18, 36, 37].